Why Do Cancer Patients Lose Their Voice?

Voice loss in cancer patients stems from a surprisingly wide range of causes, and most of them have nothing to do with cancer of the throat. A tumor in the lung can silence a vocal cord by pressing on a nerve. Surgery to remove a thyroid mass can accidentally stretch the nerve that controls vocal fold movement. Radiation can stiffen the delicate tissues that vibrate to produce sound. Even newer immunotherapy drugs have been linked to rare cases of vocal cord paralysis. Understanding why this happens, and what can be done about it, matters because voice problems affect not just communication but swallowing, breathing, and emotional well-being.

How the Voice Works and Where It Breaks Down

Your voice is produced in the larynx, a small structure in the front of the throat that houses the vocal folds (often called vocal cords). When you speak, air from the lungs passes upward through the trachea and pushes the vocal folds together so they vibrate rapidly. The pitch, volume, and quality of the sound all depend on the folds being the right shape, texture, and tension, and on the nerves that control them firing properly. Anything that disrupts the folds themselves, the nerves running to them, or the airflow powering them can change or destroy the voice.

The nerve at the center of most cancer-related voice problems is the recurrent laryngeal nerve. It branches off the vagus nerve in the chest, loops under the aorta on the left side (and under a large artery on the right), and then travels back up into the neck to reach the larynx. That long, winding path puts it in contact with the lungs, the esophagus, the thyroid, and a chain of lymph nodes. A tumor or surgical instrument touching the nerve at any point along that route can paralyze one or both vocal folds.

Tumors That Directly Damage Nerves

Lung cancer is one of the most common culprits. A mass in the upper part of the left lung sits close to where the left recurrent laryngeal nerve loops under the aortic arch, and tumor growth in that area can compress or infiltrate the nerve. When that happens, the left vocal fold stops moving and sits in a partially open position, producing a breathy, weak voice or persistent hoarseness. In some cases, this voice change is actually the first symptom that leads to the cancer diagnosis.¹ Cancers of the esophagus, mediastinal lymphomas, and metastatic disease in the chest lymph nodes can all produce the same effect by invading or pressing on the nerve along its path.

Thyroid cancer is another frequent offender. The recurrent laryngeal nerve runs just behind the thyroid gland, and aggressive thyroid tumors can grow directly into it. In one large series of patients with advanced papillary thyroid cancer that had invaded the nerve, roughly 44% already had vocal cord paralysis before any surgery was performed.² The presence of paralysis before the operation also carried prognostic weight: it was identified as a risk factor for disease progression in patients whose cancer had invaded the nerve.³ In other words, the voice change is not just a quality-of-life issue; it can signal more aggressive disease.

When Cancer Reaches the Brain

Less commonly, cancers that spread to the lining of the brain and spinal cord can cause voice changes by disrupting the cranial nerves at their origin. A condition called leptomeningeal carcinomatosis, in which cancer cells coat the membranes around the brain, can affect the vagus nerve or the nerves controlling the tongue and palate, producing slurred or weakened speech. One reported case involved a patient with an undetected gallbladder cancer who first presented with headaches, difficulty speaking, and tongue weakness before the underlying malignancy was discovered.⁴ These cases are uncommon, but they illustrate how far-reaching the effects of metastatic cancer can be.

Surgery as a Source of Voice Injury

Paradoxically, the treatment meant to cure or control cancer is one of the most frequent reasons patients lose their voice. Any operation in the neck or chest that takes place near the recurrent laryngeal nerve risks damaging it. Thyroid surgery, esophageal surgery, lung resections, and operations on the cervical spine all carry this risk.

Esophageal cancer surgery is particularly prone to causing vocal cord paralysis because surgeons must dissect close to the nerve along much of its path. In a study of nearly 400 patients who underwent minimally invasive esophagectomy, about 23% developed postoperative vocal cord paralysis. The left side was affected in the vast majority of cases.⁵ Most of these injuries resulted from nerve stretching or bruising rather than cutting, which is why the paralysis is often temporary, resolving within about six to twelve months as the nerve heals.⁶ But for some patients, the damage becomes permanent.

Thyroid cancer surgery faces the same challenge. Surgeons are improving their odds with tools like intraoperative nerve monitoring, which uses electrodes to track the nerve’s electrical activity during the operation. A randomized trial of open thyroid cancer surgery found that nerve monitoring reduced temporary vocal cord paralysis from 10% down to 2%, and helped surgeons identify the nerve in every case.⁷ The technology is not a guarantee, but it has meaningfully lowered the risk.

Even the breathing tube used during general anesthesia can cause problems. Endotracheal tubes press against the vocal folds for the duration of the surgery, and in rare cases this pressure leads to granulomas, which are small, benign growths on the vocal fold that cause persistent hoarseness weeks after the operation. Two cases were documented in women who underwent transoral thyroidectomy: both recovered well from the surgery itself but developed hoarseness about two months later when vocal cord granulomas were found at the contact point of the tube.⁸

What Radiation Does to the Vocal Folds

Radiation therapy aimed at head and neck cancers, including cancers of the larynx, pharynx, and thyroid, delivers high-energy beams through tissues that include the vocal folds. The immediate effects often involve swelling and irritation, but the long-term damage can be far more disruptive. Irradiated vocal folds develop fibrosis: excess collagen is deposited in a disorganized pattern throughout the muscle and the superficial layer just beneath the surface lining. At the same time, important structural proteins shift, and genes related to inflammation, oxidative stress, and tissue scarring become more active.⁹

The practical result is that the vocal folds become stiffer and less able to vibrate freely. They also become drier. Radiation shrinks the glands that lubricate the larynx, reducing both the amount and quality of the secretions that keep the folds moist. Patient surveys have found that up to about 88% of people who receive radiation to the larynx report abnormal voice quality afterward, though for most the impairment is mild to moderate rather than total.¹⁰ These changes continue to evolve for years after treatment ends, and the larynx remains vulnerable to progressive, late-onset dysfunction in head and neck cancer survivors.¹¹

Radiation also triggers compensatory muscle behaviors that compound the problem. When the vocal folds are stiff and dry, patients unconsciously squeeze the muscles of the larynx harder to produce sound. Over time, this habitual strain develops into muscle tension dysphonia, a condition where the voice is effortful and rough even when the vocal folds themselves have healed as much as they are going to. A study of 128 head and neck cancer patients who sought help for voice complaints after radiation or chemoradiation found hyperactivity and compression of both the true and false vocal folds in about 80% of cases.¹² This maladaptive pattern can persist long after the cancer is gone, meaning that treatment for the voice problem needs to address the tension, not just the tissue damage.

Immunotherapy and Rare Drug Reactions

The newest class of cancer drugs, immune checkpoint inhibitors like pembrolizumab, work by releasing the brakes on the immune system so it can attack cancer cells. The trade-off is that the revved-up immune system sometimes attacks healthy tissues too. Most oncologists are familiar with immune-related side effects in the thyroid, liver, skin, and gut, but the recurrent laryngeal nerve can also be caught in the crossfire. Case reports have documented bilateral vocal cord paralysis linked to pembrolizumab therapy, likely caused by immune-mediated inflammation affecting the nerve or the neuromuscular junction.¹³ Bilateral paralysis is more dangerous than one-sided paralysis because both folds can drift toward the midline, narrowing the airway. These cases remain rare, but as immunotherapy becomes more widely used across cancer types, awareness among patients and clinicians matters.

Corticosteroids, which cancer patients often take to manage inflammation, swelling, or nausea, can also affect the voice when injected directly into the vocal folds for other conditions. Repeated steroid injections have been shown to cause temporary vocal fold atrophy, thinning the tissue and creating a gap between the folds that produces a weak, breathy voice. In documented cases, the atrophy resolved on its own within several months, but the interim period was functionally debilitating.¹⁴ This is relevant for cancer patients who may already have radiation-damaged vocal folds and then receive steroid injections to treat stiffness or scarring.

Total Laryngectomy and the Complete Loss of Natural Voice

For advanced laryngeal cancer, or for cancers that recur after radiation, sometimes the entire larynx must be surgically removed. This operation, called a total laryngectomy, permanently eliminates the natural voice because the vocal folds are gone. The airway is also rerouted: the trachea is brought to an opening in the front of the neck (a stoma), and the person breathes through that opening rather than through the nose or mouth. The impact goes beyond speech. Patients lose the ability to smell normally, cannot blow their nose, and face an adjustment period that many describe as profound.

Research into quality of life after total laryngectomy has consistently shown significant drops in both physical and mental well-being. One study found that physical health scores decreased by roughly 24% and mental health scores by about 23% compared to a control group without cancer. Patients who lost their voice completely after total laryngectomy fared worse than those who had undergone partial resection and retained some natural voice.¹⁵ Alternative speech methods exist, including tracheoesophageal puncture (where a small valve is placed between the trachea and esophagus to redirect air), electrolarynx devices, and esophageal speech, but none replicate the natural voice, and each comes with its own learning curve.

Restoring or Improving the Voice

For patients with vocal cord paralysis from nerve damage rather than total removal of the larynx, several effective treatments exist. The most common starting point is injection laryngoplasty, a procedure in which a filler material is injected into the paralyzed vocal fold to push it toward the midline so it can meet the opposite fold during speech. A study of cancer-related one-sided vocal cord paralysis found that injection laryngoplasty significantly improved the gap between the folds, the amount of time patients could sustain a note, and self-reported voice handicap scores. The improvements appeared within two weeks and held at three months.¹⁶

Timing turns out to matter quite a bit. When injection is performed within the first three months after paralysis begins, patients are much less likely to need more invasive surgery later. In one study, only about 5% of patients injected within three months eventually required permanent laryngeal framework surgery, compared to more than 70% of those who waited beyond six months.¹⁷ The early injection buys time for the nerve to potentially recover on its own while keeping the voice functional in the interim.

When paralysis becomes permanent and injections are not enough, surgical options include type 1 thyroplasty, where an implant is placed through a small window in the thyroid cartilage to reposition the paralyzed fold, and arytenoid adduction, which adjusts the cartilage at the back of the larynx to change the fold’s position and tension. Both approaches have been shown to produce effective voice recovery when selected appropriately for the individual patient’s anatomy.¹⁸

Speech Therapy After Cancer Treatment

Not every voice problem requires a procedure. For patients whose voice changes stem from radiation fibrosis, muscle tension, or mild weakness rather than complete nerve paralysis, structured voice therapy can make a real difference. One program studied specifically in head and neck cancer patients used a series of targeted exercises focusing on abdominal breathing, laryngeal control, resonance, and vocal range. Patients who completed the program showed statistically significant improvements in voice steadiness, how long they could hold a note (increasing from about 10.5 seconds to over 15 seconds on average), self-rated voice handicap, and pitch range.¹⁹

Voice therapy is not glamorous compared to surgery, and it requires consistent effort from the patient, but it addresses a dimension that no procedure can: the habitual muscle patterns that develop when someone has been compensating for a damaged voice for months or years. Many cancer survivors end up benefiting from a combination of approaches, perhaps an injection to close a vocal fold gap followed by therapy to retrain the way they use their voice. The best outcomes tend to come from early referral to a laryngologist and speech-language pathologist, ideally before poor compensatory habits have had time to solidify.

Why This Gets Overlooked

Voice problems in cancer patients often receive less attention than they deserve because they are not life-threatening in the way that tumor growth, metastasis, or organ failure are. Oncology teams are understandably focused on survival. But the voice is central to a person’s identity and independence. Losing it affects the ability to work, to participate in family life, to communicate pain or needs during treatment, and to maintain social connections during one of the most isolating experiences a person can go through. Patients sometimes hesitate to bring up voice concerns because they feel they should be grateful to be alive, or because they assume nothing can be done. Both assumptions are wrong. Treatments exist for nearly every type of cancer-related voice loss, and the earlier they are pursued, the better the outcomes tend to be.